Directory at Vanderbilt-Ingram Cancer Center
Search or browse for cancer center researchers, leadership and key staff by last name, research program or department.
Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.
No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.
Translational Research and Interventional Oncology Research Program
The Translational Research and Interventional Oncology Research Program translates advances in mechanism-based research into improved detection methods and therapies for cancer. With a primary focus on lung cancer, melanoma and leukemia/lymphoma, the program is dedicated to new discoveries in early detection and molecular oncology, and genotype-driven early phase trials for all cancer types.
Cancer Epidemiology Research Program
The Cancer Epidemiology Research Program aims to improve our understanding of the genetic and environmental origins of cancer and to identify biomarkers for cancer risk and progression. This understanding informs the design of effective cancer prevention and control programs.
Cancer Health Outcomes & Control Research Program
The Cancer Health Outcomes and Control Program conducts research aimed at reducing the burden of cancer across the entire cancer care continuum. The research efforts of this interdisciplinary, collaborative program center on the themes of:
- Prevention and Early Detection
- Treatment-Related Outcomes
- Survivorship and Palliative Care
Gastrointestinal Cancer Research Program
Gastrointestinal (GI) cancers remain some of the most difficult to treat, with five-year survival rates below 50 percent for most GI cancer types.
The Gastrointestinal Cancer Research Program aims to better understand what drives these cancers with the goal of identifying and applying better treatment strategies. Our research efforts span the entire spectrum—from in-depth basic research to investigator-initiated clinical trials—across all GI cancer types, including colorectal, gastroesophageal, and pancreatic cancers.
Genome Maintenance Research Program
DNA damage and response is involved at all stages of the cancer lifecycle—from cancer onset to progression and response to therapies. The Genome Maintenance Research Program is a cohesive network of basic science researchers focused on understanding how DNA is damaged, repaired, packaged, expressed, and replicated.